Safety and efficacy of lacosamide versus phenytoin for refractory seizures in neurosurgical patients
Background Postoperative neurosurgical patients have increased risk of seizures. Traditional anti-epileptics, such as phenytoin, are not always effective and cause adverse effects. Levetiracetam is the first-line therapy due to its similar efficacy and more favourable side effect profile. However, m...
Main Authors: | Sarah Schaidle, Kasey Greathouse, Deepika McConnell |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-05-01
|
Series: | BMJ Neurology Open |
Online Access: | https://neurologyopen.bmj.com/content/3/1/e000144.full |
Similar Items
-
New treatment option for partial-onset seizures: efficacy and safety of lacosamide
by: Steve S. Chung
Published: (2010-03-01) -
Efficacy and Safety of Lacosamide in Adolescents with Lennox-Gastaut Syndrome
by: Han Som Choi, et al.
Published: (2020-07-01) -
Lacosamide for the prevention of partial onset seizures in epileptic adults
by: Anna Kelemen, et al.
Published: (2010-07-01) -
Genomic and clinical predictors of lacosamide response in refractory epilepsies
by: Sinéad B. Heavin, et al.
Published: (2019-12-01) -
Phenytoin for Post-Traumatic Seizures
by: J Gordon Millichap
Published: (1990-09-01)